Muscle mass drives resting metabolic rate, supports joint health, improves insulin sensitivity, and becomes increasingly important for long-term weight maintenance after GLP-1 treatment ends
Yes, peptides can complement other treatments like physical therapy, chiropractic care, and pain management strategies
Key facts Kaiser California base plans exclude GLP-1 weight-loss drugs for new starts with BMI below 40 (since January 2025) a more restrictive threshold than Wegovy's FDA indication (BMI 30+), matching the Blue Shield of California restriction applied at the same time
[/custom tab]
von Heesen M, Schuld J, Sperling J, et al
Cell 129 , 12611274 (2007)